2026年生物醫(yī)學(xué)研究英語(yǔ)試題集_第1頁(yè)
2026年生物醫(yī)學(xué)研究英語(yǔ)試題集_第2頁(yè)
2026年生物醫(yī)學(xué)研究英語(yǔ)試題集_第3頁(yè)
2026年生物醫(yī)學(xué)研究英語(yǔ)試題集_第4頁(yè)
2026年生物醫(yī)學(xué)研究英語(yǔ)試題集_第5頁(yè)
已閱讀5頁(yè),還剩10頁(yè)未讀 繼續(xù)免費(fèi)閱讀

付費(fèi)下載

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

2026年生物醫(yī)學(xué)研究英語(yǔ)試題集Part1:ReadingComprehension(閱讀理解)共5題,每題2分,總分10分Passage1TherapidadvancementofCRISPR-Cas9geneeditingtechnologyhasrevolutionizedbiomedicalresearch,particularlyinthetreatmentofgeneticdisorders.However,ethicalconcernsandoff-targeteffectsremainsignificantchallenges.ArecentstudypublishedinNatureBiotechnologydemonstratedthatrefinedCRISPRsystems,suchashigh-fidelityCas9variants,canminimizeunintendedgeneticmodifications.ResearchersattheUniversityofCambridgetestedthesevariantsinhumancelllinesandfounda90%reductioninoff-targetcutscomparedtotraditionalCas9.Theimplicationsforclinicalapplicationsaresubstantial,thoughregulatoryapprovalremainsyearsaway.Questions:1.Whatisthemainpurposeofthepassage?A)TocriticizethelimitationsofCRISPR-Cas9.B)Tohighlighttheethicalissuesingeneediting.C)TodiscussadvancementsinCRISPRtechnology.D)Topredictthefutureofgeneticdisordertreatments.2.Accordingtothepassage,whatisakeyconcernaboutCRISPR-Cas9?A)Itshighcost.B)Off-targeteffects.C)Regulatorydelays.D)Limitedresearchfunding.3.WhichinstitutionismentionedasconductingresearchonCRISPR?A)TheNationalInstitutesofHealth.B)TheUniversityofCambridge.C)TheChineseAcademyofSciences.D)TheEuropeanMolecularBiologyLaboratory.4.Whatdoesthephrase"high-fidelityCas9variants"suggest?A)Cas9withimprovedaccuracy.B)Cas9withbroaderapplications.C)Cas9withfastereditingspeed.D)Cas9withfewersideeffects.5.Whatisthemostlikelynextstepforthetechnologymentionedinthepassage?A)Large-scaleclinicaltrials.B)Completeregulatoryapproval.C)Furtherlaboratorytesting.D)Publicdebateonethics.Passage2Moleculardiagnosticshasseensignificantgrowthinthepastdecade,drivenbynext-generationsequencing(NGS)technologies.A2025reportbytheWorldHealthOrganization(WHO)notedthatNGS-basedtestsareimprovingearlydetectionofcancers,infectiousdiseases,andinheritedconditions.However,challengesremain,includinghighcostsandtheneedforspecializedpersonnel.ResearchersinSingaporehavedevelopedaportableNGSdevicethatcanperformcomprehensivegeneticanalysesinunder2hours,makingitviableforresource-limitedsettings.Thisinnovationcouldtransformglobalhealthcareaccess,thoughscalabilityremainsaconcern.Questions:1.Whatistheprimaryfocusofthepassage?A)TheeconomicimpactofNGS.B)Thechallengesofmoleculardiagnostics.C)Innovationsingenetictestingtechnology.D)TheroleofWHOinhealthcare.2.Accordingtothepassage,whatisamajorlimitationofcurrentNGStechnologies?A)Accuracyissues.B)Highcosts.C)Slowprocessingtime.D)Limitedapplications.3.WhichcountryishighlightedasaleaderindevelopingportableNGSdevices?A)theUnitedStatesB)theUnitedKingdomC)SingaporeD)Japan4.Whatdoesthephrase"resource-limitedsettings"mostlikelyreferto?A)Developedcountrieswithadvancedlabs.B)Countrieswithlimitedhealthcareinfrastructure.C)Urbanareaswithhighpopulationdensity.D)Researchinstitutionswithamplefunding.5.Whatistheauthor’slikelystanceonthefutureofNGS?A)Skepticalduetohighcosts.B)Optimisticaboutglobalaccessibility.C)Neutralontechnologicalimpact.D)Concernedaboutregulatoryhurdles.Part2:VocabularyinContext(詞匯應(yīng)用)共5題,每題2分,總分10分Instructions:Fillintheblankswiththemostappropriatewordsfromthelistbelow.Eachwordcanonlybeusedonce.1.Thenewdrugcandidatehasshownpromisein__________trialsbutrequiresfurthertestingforlong-termefficacy.(A)preliminary(B)conclusive(C)invasive(D)repetitive2.Advancesin__________technologieshaveenabledmoreprecisesurgicalinterventions.(A)nanomedicine(B)telemedicine(C)pharmacology(D)immunology3.Thestudyhighlightsthe__________roleofmicroRNAsinregulatinggeneexpression.(A)negligible(B)pivotal(C)ambiguous(D)superficial4.Researchersareexploring__________therapiestotreatantibiotic-resistantbacteria.(A)conventional(B)innovative(C)outdated(D)empirical5.Thepatient’ssymptomswere__________totheadministeredmedication,suggestingasevereallergicreaction.(A)resistant(B)sensitive(C)unrelated(D)consistentPart3:GrammarandSentenceStructure(語(yǔ)法與句型)共5題,每題2分,總分10分Instructions:Choosethebestoptiontocompleteeachsentence.1.Iftheexperiment__________conductedundercontrolledconditions,theresultswouldbemorereliable.A)hadbeenB)wereC)willbeD)hasbeen2.Despitethe__________challenges,theteammanagedtocompletetheprojectontime.A)insurmountableB)negligibleC)manageableD)inevitable3.ThebreakthroughinmRNAvaccinetechnology__________bytherapidspreadofCOVID-19.A)wasdrivenB)drivesC)wasdrivingD)haddriven4.Neithertheresearchersnorthefundingagency__________satisfiedwiththepreliminaryfindings.A)isB)areC)wasD)were5.Thepatient’srecovery__________dependentonconsistentmedicationandphysicaltherapy.A)willbeB)isC)hasbeenD)wouldbePart4:SummaryCompletion(摘要填空)共4題,每題3分,總分12分Passage:ArecentstudypublishedinScienceexaminedtheeffectsofchronicstressonimmunesystemfunction.ResearchersatStanfordUniversityfoundthatprolongedstresscanleadtodysregulationofcytokineproduction,increasingsusceptibilitytoinfections.Thestudyinvolved200participants,halfofwhomwereexposedtohigh-stressenvironmentsfor6months.Thoseinthestressedgroupexhibitedhigherlevelsofcortisolandlowerlymphocytecounts.Thefindingssuggestthatstressmanagementtechniques,suchasmindfulnessmeditation,couldmitigatetheseeffects.Thestudyalsohighlightedtheneedforfurtherresearchonstress-immuneinteractionsindiversepopulations.Questions:1.Whatisthemainfocusofthestudy?__________2.Howmanyparticipantswereinvolvedintheresearch?__________3.Whatwerethekeyphysiologicalchangesobservedinthestressedgroup?__________4.Whatrecommendationsdidtheresearchersmakeforfutureinterventions?__________Part5:Translation(翻譯)共2題,每題5分,總分10分1.TranslatethefollowingsentenceintoEnglish:"近年來,中國(guó)科學(xué)家在阿爾茨海默病的研究中取得了顯著進(jìn)展,特別是在β-淀粉樣蛋白的病理機(jī)制方面。"2.TranslatethefollowingsentenceintoChinese:"Theintegrationofartificialintelligenceintomedicalimaginghasimproveddiagnosticaccuracybutraisesconcernsaboutdataprivacy."AnswerKeyandExplanationPart1:ReadingComprehension1.C2.B3.B4.A5.A6.C7.C8.B9.D10.BExplanation:1.ThepassageprimarilydiscussesadvancementsinCRISPRtechnology(OptionC).2.Off-targeteffectsareexplicitlymentionedasakeyconcern(OptionB).3.TheUniversityofCambridgeistheinstitutionhighlighted(OptionB).4."High-fidelityCas9variants"implyimprovedaccuracy(OptionA).5.Clinicaltrialsarethemostlogicalnextstep(OptionA).Part2:VocabularyinContext1.A(preliminary)2.A(nanomedicine)3.B(pivotal)4.B(innovative)5.B(sensitive)Explanation:1."Preliminarytrials"isthecorrecttermforinitialtesting(OptionA).2.Nanomedicineisarelevanttechnologyforpreciseinterventions(OptionA).3.MicroRNAsplaya"pivotal"roleingeneregulation(OptionB).4.Researchersareexploring"innovative"therapiesforantibioticresistance(OptionB).5.Thepatient’ssymptomswere"sensitive"tothemedication(OptionB).Part3:GrammarandSentenceStructure1.A(hadbeen)2.C(manageable)3.A(wasdriven)4.B(are)5.B(is)Explanation:1.Thesent

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論